Revenue by segment/product/region: Life Science Products
Flow – sum over the period · $M
Q4 2025
244a$M
derived
All values (36)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 2025 | 244 | derived |
| Q3 2025 | 241 | reported |
| Q2 2025 | 246 | reported |
| Q1 2025 | 228 | reported |
| Q4 2024 | 236 | derived |
| Q3 2024 | 235 | reported |
| Q2 2024 | 237 | reported |
| Q1 2024 | 225 | reported |
| Q4 2023 | 232 | derived |
| Q3 2023 | 221 | reported |
| Q2 2023 | 222 | reported |
| Q1 2023 | 247 | reported |
| Q4 2022 | 279 | derived |
| Q3 2022 | 297 | reported |
| Q2 2022 | 304 | reported |
| Q1 2022 | 307 | reported |
| Q4 2021 | 315 | derived |
| Q3 2021 | 304 | reported |
| Q2 2021 | 312 | reported |
| Q1 2021 | 301 | reported |
| Q4 2020 | 274 | derived |
| Q3 2020 | 220 | reported |
| Q2 2020 | 236 | reported |
| Q1 2020 | 251 | reported |
| Q4 2019 | 251 | derived |
| Q3 2019 | 250 | reported |
| Q2 2019 | 255 | reported |
| Q1 2019 | 239 | reported |
| Q4 2018 | 238 | derived |
| Q3 2018 | 231 | reported |
| Q2 2018 | 245 | reported |
| Q1 2018 | 232 | reported |
| Q4 2017 | 225 | derived |
| Q3 2017 | 223 | reported |
| Q2 2017 | 221 | reported |
| Q1 2017 | 210 | reported |
6 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: seg_revenue / glw:LifeScienceProductsMember
More metrics for Corning
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
- Other
- Other
- Other
- Asia Pacific
- Automotive Products
- Display Products
- Display Technologies
- Electronics Glass & Advanced Optics Products
- Environmental Substrate & Filter Products
- Environmental Technologies
- Europe
- Life Science Products
- Life Sciences
- North America
- Optical Communications
- Optical Communications Products
- Other
- Other
- Polycrystalline Silicon
- Polycrystalline Silicon & Solar Products
- Polycrystalline Silicon Products
- Other
- Specialty Glass Products
- Specialty Materials
- Specialty Materials Products
- Telecommunication Products
- Land CA
- Land CN
- Land DE
- Land JP
- Land KR
- Land MX
- Land TW
- Land US
Sources & calculation
- Value
- $244M (derived)
- Period
- Q4 2025, ended Dec 31, 2025 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 959M − 715M = $244M (FY value from 10-K 0000024741-26-000124; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 12, 2026 · 0000024741-26-000124
- Location
- us-gaap:Revenues [srt:ProductOrServiceAxis=glw:LifeScienceProductsMember]
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $244M | Feb 12, 2026 | 10-K 0000024741-26-000124 | derived · confidence 1. · current |